Please login to the form below

Not currently logged in
Email:
Password:

China recalls tainted leukaemia drugs

The Chinese state food and drug administration orders the recall of two contaminated leukaemia drugs which have caused adverse reactions among children

The Chinese state food and drug administration (SFDA) has ordered the recall of two contaminated leukaemia drugs which have caused adverse reactions among children.

The drugs, the majority of which were produced by a Shanghai-based pharmaceutical company have already been recovered and authorities have reportedly tracked down the remainder, according to local media reports.

The Chinese Health Ministry and the SFDA suspended production and sale of methotrexate and cytarabin, after receiving reports that several child leukaemia patients had suffered mobility impairments after treatment. The drugs had also caused urine retention among some leukaemia patients.

Both authorities said the drugs were contaminated with an anti-cancer medicine which had been added mistakenly during production and the factories manufacturing the drugs have been closed.

The new head of the new food, drug and product safety teams in China, vice-premier Wu Yi, or the "Iron Lady" as she has been dubbed, has suspended the licenses of 1,200 drug and medical equipment companies.

Wu Yi brokered the trade agreements with Russia and the US in the late 1990s, which smoothed China's entry into the World Trade Organisation in 2001.

17th September 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency. We dispense pioneering and creative campaigns, driven by...

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics